Kryxana Tablet 200 mg is an anticancer therapy, typically containing the active ingredient (API) ribociclib. It is given in combination with other medications. The kryxana 200 mg is used in women to treat a kind of breast cancer (hormone receptor +Ve, HER2 negative) that is locally advanced or has progressed to other parts of the body. Tablets of Kryxana are not recommended for adolescents and children aged under 18 years. Before starting to take this medicine, it is absolutely vital to inform your health specialist if you have any signs/symptoms of infections (mouth ulcers, fever or sore throat), liver/heart disorders, or if you're allergic to peanuts or soya. Use appropriate birth control during the therapy and for at least 21 days after the final dose.